Anti-Human TNFRSF10A Therapeutic Antibody (4E7.24.3)
The antibody binds to DR4, but not to any of the other Apo-2L receptors, Apo-2, DcRl, or DcR2. It can be potentially used in the treatment of various diseases and pathological conditions, including cancer.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-162CQ |
Pricing | Inquiry |
Applications | FC, ELISA, Block |
Host | Mouse |
Target | DR4 (Death receptor 4) |
Species Reactivity | Human |